Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
enzalutamide - Google News
Get the latest updates from enzalutamide - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 3 hours ago
Pfizer’s New Phase 3 Trial: A Potential Game-Changer in Prostate Cancer Treatment? - TipRanks
about 21 hours ago
Pfizer’s New Phase 3 Trial: A Potential Game-Changer in Prostate Cancer Treatment...
Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling - Nature
about 22 hours ago
Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through...
Pfizer’s New Study on Mevrometostat and Enzalutamide: Potential Game-Changer in Prostate Cancer Treatment? - The Globe and Mail
2 days ago
Pfizer’s New Study on Mevrometostat and Enzalutamide: Potential Game-Changer in Prostate Cancer...
FDA news recap in urology for Q2 2025 - Urology Times
2 days ago
FDA news recap in urology for Q2 2025 Urology Times
Enzalutamide Plus Androgen-Deprivation Therapy Shows Durable Survival Benefit for Patients With Metastatic Hormone-Sensitive Prostate Cancer - HMP Global Learning Network
3 days ago
Enzalutamide Plus Androgen-Deprivation Therapy Shows Durable Survival Benefit for Patients With Metastatic...
Pfizer’s New Study on Mevrometostat and Enzalutamide: Potential Game-Changer in Prostate Cancer Treatment? - TipRanks
3 days ago
Pfizer’s New Study on Mevrometostat and Enzalutamide: Potential Game-Changer in Prostate Cancer...
ZFHX3 is integral to androgen/AR signaling involving protein association with AR in prostate cancer cells - Nature
4 days ago
ZFHX3 is integral to androgen/AR signaling involving protein association with AR in...
Yüksel Ürün: New Player in ARPI-Resistant Prostate Cancer - Oncodaily
5 days ago
Yüksel Ürün: New Player in ARPI-Resistant Prostate Cancer Oncodaily
Pfizer’s Promising Phase 3 Study on Prostate Cancer Treatment: A Potential Game Changer - TipRanks
5 days ago
Pfizer’s Promising Phase 3 Study on Prostate Cancer Treatment: A Potential Game...
Insights From the PEACE III Trial - Targeted Oncology
5 days ago
Insights From the PEACE III Trial Targeted Oncology
Elevated CXCR7 in enzalutamide-resistant (EnzR) prostate cancer cells... - researchgate.net
6 days ago
Elevated CXCR7 in enzalutamide-resistant (EnzR) prostate cancer cells... researchgate.net
C4-2B MDVR cells are resistant to enzalutamide in vitro and in vivo. A,... - researchgate.net
7 days ago
C4-2B MDVR cells are resistant to enzalutamide in vitro and in vivo...